Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Total Liabilities (2020 - 2025)

Universe Pharmaceuticals' Total Liabilities history spans 5 years, with the latest figure at $22.5 billion for Q3 2024.

  • For Q3 2024, Total Liabilities rose 163124.63% year-over-year to $22.5 billion; the TTM value through Sep 2024 reached $22.5 billion, up 163124.63%, while the annual FY2024 figure was $22.5 billion, 163124.63% up from the prior year.
  • Total Liabilities for Q3 2024 was $22.5 billion at Universe Pharmaceuticals, up from $13.8 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $22.5 billion in Q3 2024 and bottomed at -$35.3 billion in Q3 2022.
  • The 5-year median for Total Liabilities is $13.8 million (2023), against an average of -$2.6 billion.
  • The largest annual shift saw Total Liabilities crashed 152442.21% in 2022 before it surged 163124.63% in 2024.
  • A 5-year view of Total Liabilities shows it stood at -$20.8 million in 2020, then surged by 211.29% to $23.2 million in 2021, then plummeted by 152442.21% to -$35.3 billion in 2022, then surged by 100.04% to $13.8 million in 2023, then soared by 163124.63% to $22.5 billion in 2024.
  • Per Business Quant, the three most recent readings for UPC's Total Liabilities are $22.5 billion (Q3 2024), $13.8 million (Q3 2023), and -$35.3 billion (Q3 2022).